Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
Abstract
Decades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-specific death rates in different European countries related to changes in life expectancy in those countries before and during the COVID-19 pandemic.
We used data and methods from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 to compare changes in life expectancy at birth, causes of death, and population exposure to risk factors in 16 European Economic Area countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, and Sweden) and the four UK nations (England, Northern Ireland, Scotland, and Wales) for three time periods: 1990-2011, 2011-19, and 2019-21. Changes in life expectancy and causes of death were estimated with an established life expectancy cause-specific decomposition method, and compared with summary exposure values of risk factors for the major causes of death influencing life expectancy.
Citation impact
- FWCI
- 36.12
- Percentile
- 100%
- References
- 48
Authors
617Topics & keywords
- Life expectancy
- Disease
- Environmental health
- Burden of disease
- Medicine
- Population
- Pathology
Funding
- UEU.S. Environmental Protection Agency
- BABill and Melinda Gates Foundation
- SSanofi
- YUYale University
- GSGilead Sciences
- UOUniversity of Pennsylvania
- HUHarvard University
- JHJohns Hopkins University
- UOUniversity of Montana
- WTWellcome Trust
- UPUltragenyx Pharmaceutical
- URUK Research and Innovation
- NCNational Cerebral and Cardiovascular Center
- APAmryt Pharma
- GOGovernment of Canada
- CUCardiff University
- AAAustralian Academy of Science
- MOMinistry of Education, Culture, Sports, Science and TechnologyAward: P23712
- ARAXA Research Fund
- KUKorea University
- FCFondazione Cariplo
- FBFondation Botnar
- AMApplied Molecular Biosciences UnitAwards: LA/P/0140/2020, UIDP/04378/2020, UIDB/04378/2020
- UOUniversity of West Attica
- NINational Institutes of Health
- IFInstitute for Biospheric Studies, Yale University
- HCHealth CanadaAward: PAC-10
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAward: MR/M015084/1
- JSJapan Society for the Promotion of ScienceAwards: 23KF0126, P23712
- FPFundação para a Ciência e a TecnologiaAwards: UIDB/04378/2020, UIDP/04378/2020, LA/P/0140/2020